Brief: China Resources Pharmaceutical Posts 9M Revenue For CR Boya Bio-Pharmaceutical Of RMB 1.25 Bln
Oct 24 (Reuters) - China Resources Boya Bio
pharmaceutical Group Co Ltd 300294.SZ :
* 9M REVENUE FOR CR BOYA BIO-PHARMACEUTICAL RMB 1.25 BILLION
* 9M NET PROFIT FOR CR BOYA BIO-PHARMACEUTICAL RMB412.4
MILLION
Further company coverage: 300294.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals